Glucose Metabolism Disorders  >>  pioglitazone  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

27 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00449553: Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.

Completed
N/A
326
Europe, RoW
Pioglitazone and sulphonylurea, ACTOS®, AD4833, Pioglitazone and metformin
Takeda, Eli Lilly and Company
Diabetes Mellitus
09/03
09/03
NCT00308373: Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes Mellitus

Completed
N/A
73
US
Metformin vs Thiazolidinedione (Pioglitazone)
Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes Mellitus, Type 2
11/05
11/05
NCT01258322: Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients

Checkmark Data
Mar 2012 - Mar 2012: Data
Completed
N/A
70
RoW
Pioglitazone, pioglitazone (Actos®, Takeda®) 15mg
Huashan Hospital, Baxter Healthcare Corporation
Peritoneal Dialysis, Pioglitazone, Hypertriglyceridemia, Insulin Resistance, Inflammation
09/08
09/08
NCT00639457: Exercise and Pioglitazone for HIV-Metabolic Syndromes

Completed
N/A
44
US
Pioglitazone, Actos, Exercise training, Physical activity
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
HIV Infections, Type 2 Diabetes, Obesity, HIV, AIDS, Cardiovascular Disease, Lipodystrophy
12/08
12/09
NCT00722631: Anti-Inflammatory Effects of Pioglitazone

Completed
N/A
70
Japan
Pioglitazone, CAS number: 111025-46-8, ATC code: A10BG03, Glimepiride, CAS number: 93479-97-1, ATC code: A10BB12
Kurume University
Impaired Glucose Tolerance, Type 2 Diabetes Mellitus, Atherosclerosis
04/09
04/12
NCT00892372: Relationship Between Body Weight and Glycohemoglobin

Completed
N/A
100
Japan
Saitama Medical University
Type 2 Diabetes Mellitus
04/09
04/09
WU197, NCT00656851: Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome

Completed
N/A
24
US
Pioglitazone, Actos, Exercise Training, Physical activity, Aerobic exercise, Weight lifting exercise
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
HIV Infections, Cardiovascular Disease, Insulin Resistance, HIV Lipodystrophy, The Metabolic Syndrome
08/09
08/10
NCT00426413: Ketosis Prone Diabetes in African-Americans

Completed
N/A
44
US
pioglitazone, Actos (pioglitazone)
Emory University
Ketosis Prone Diabetes, Diabetic Ketoacidosis, Severe Hyperglycemia
08/10
08/10
NCT02181842: Pioglitazone Tablets Specified Drug-use Survey

Completed
N/A
246
NA
Pioglitazone, Actos Tablets
Takeda
Type 2 Diabetes Mellitus
06/11
06/11
NCT02678676: An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications

Completed
N/A
3599
Europe, RoW
No Intervention
Takeda
Diabetes Mellitus, Type 2
11/11
11/11
NCT02003014: Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Biguanides / Long-term Treatment"

Completed
N/A
899
Japan
Pioglitazone, Actos
Takeda
Type 2 Diabetes Mellitus
01/12
01/12
NCT01570660: Phielix et al.: Hepatic Fat Content and Adipokines

Completed
N/A
24
Europe
Pioglitazone
German Diabetes Center
Type 2 Diabetes Mellitus
03/12
03/12
ADT, NCT00743327: Androgen Deprivation Therapy Study

Terminated
N/A
1
US
Pioglitazone, Actos
National Institute on Aging (NIA)
Hypogonadism, Metabolic Syndrome, Diabetes, Inflammation
08/12
08/12
NCT01147627: Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients

Completed
N/A
416
RoW
exenatide injection, Byetta®(Eli Lilly and Company), Mixed Protamine Zinc Recombinant Human Insulin Lispro 25R, Humalog Mix 25®（Eli Lilly and Company), Pioglitazone
Sun Yat-sen University, Eli Lilly and Company, Amylin Pharmaceuticals, LLC., Ministry of Health, China
Diabetes Mellitus, Type 2, Newly Diagnosed
08/12
12/12
NCT00763139: Inflammation and Insulin Resistance in Rheumatoid Arthritis

Completed
N/A
34
US
Pioglitazone, Actos, Placebo
Vanderbilt University, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Rheumatoid Arthritis
09/12
12/13
NCT00470262: Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation

Completed
N/A
27
US
Fenofibrate 145mg PO QD, Tricor, Pioglitazone 45 mg PO QD, Actos
VA Office of Research and Development
Metabolic Syndrome X, Prediabetic State
12/12
06/14
NCT02002975: Pioglitazone Special Drug Use Surveillance "Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus"

Completed
N/A
18223
NA
Pioglitazone, ACTOS
Takeda
Type 2 Diabetes Mellitus
06/13
06/13
NCT01289639: Insulin Resistance in Non-alcoholic Fatty Liver Disease

Terminated
N/A
11
US
fenofibrate, micronized fenofibrate, pioglitazone, Actos, placebo
VA Office of Research and Development
Fatty Liver
08/13
08/14
NCT02068508: Pioglitazone Tablets Special Drug Use Surveillance "Combined Use of Insulin Products / Long-term Treatment"

Completed
N/A
1067
NA
Pioglitazone, Actos
Takeda
Type 2 Diabetes Mellitus
06/14
06/14
NCT02192684: Obesity, Sleep Apnea, and Insulin Resistance

Completed
N/A
45
US
Pioglitazone, actos, placebo
Stanford University
Insulin Sensitivity, Obstructive Sleep Apnea
07/14
03/15
NCT02098746: Pioglitazone/Glimepiride (Sonias) Combination Tablets Special Drug Use Surveillance Survey in Patients With Type 2 Diabetes Mellitus Who Respond Poorly to Pioglitazone

Completed
N/A
294
Japan
Pioglitazone/glimepiride, Sonias combination tablets LD
Takeda
Type 2 Diabetes
07/14
07/14
NCT01637935: Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes

Completed
N/A
193099
NA
Pioglitazone, Actos
Takeda, Kaiser Permanente, Department of Epidemiology at University of Pennsylvania
Diabetes, Bladder Cancer
08/14
08/14
ZODIAC-39, NCT02133118: Weight Trajectory in New Users of Sulfonylureas as Add on Therapy Next to Metformin.

Completed
N/A
16293
Europe
individual SUs, insulin, pioglitazone
Medical Research Foundation, The Netherlands
Type 2 Diabetes Mellitus
12/14
12/14
NCT02475499: Incretin-based Drugs and Pancreatic Cancer

Completed
N/A
886172
Canada
DPP-4 inhibitors, incretin-based drugs, sitagliptin, vildagliptin, saxagliptin, GLP-1 analogs, exenatide, liraglutide, Sulfonylureas, oral hypoglycemic agent, glibenclamide, chlorpropamide, tolbutamide, glibornuride, tolazamide, carbutamide, glipizide, gliquidone, gliclazide, metahexamide, glisoxepide, glimepiride, acetohexamide, glymidine, Biguanides, phenformin, metformin, buformin, Thiazolidinediones, troglitazone, rosiglitazone, pioglitazone, Alpha-glucosidase inhibitors, acarbose, miglitol, voglibose, Meglitinides, repaglinide, nateglinide
Canadian Network for Observational Drug Effect Studies, CNODES, Drug Safety and Effectiveness Network, Canada, Canadian Institutes of Health Research (CIHR)
Diabetes Mellitus, Type 2
04/15
04/15
NCT02476760: Incretin-based Drugs and Acute Pancreatitis

Completed
N/A
1417914
Canada
DPP-4 inhibitors, incretin-based drugs, sitagliptin, vildagliptin, saxagliptin, GLP-1 analogs, exenatide, liraglutide, Insulins, insulins and analogues for injection, fast-acting, insulins and analogues for injection, intermediate-acting, insulins and analogues for injection, long-acting, insulins and analogues for inhalation, Biguanides, oral hypoglycemic agent, phenformin, metformin, buformin, Sulfonylureas, glibenclamide, chlorpropamide, tolbutamide, glibornuride, tolazamide, carbutamide, glipizide, gliquidone, gliclazide, metahexamide, glisoxepide, glimepiride, acetohexamide, glymidine, Thiazolidinediones, troglitazone, rosiglitazone, pioglitazone, Alpha-glucosidase inhibitors, acarbose, miglitol, voglibose, Meglitinides, repaglinide, nateglinide
Canadian Network for Observational Drug Effect Studies, CNODES, Drug Safety and Effectiveness Network, Canada, Canadian Institutes of Health Research (CIHR)
Diabetes Mellitus, Type 2
04/15
04/15
NCT02456428: Incretin-based Drugs and the Risk of Heart Failure

Completed
N/A
1499650
Canada
DPP-4 inhibitors, incretin-based drugs, sitagliptin, vildagliptin, saxagliptin, GLP-1 analogs, exenatide, liraglutide, Insulins, insulins and analogues for injection, fast-acting, insulins and analogues for injection, intermediate-acting, insulins and analogues for injection, long-acting, insulins and analogues for inhalation, Biguanides, oral hypoglycemic agent, phenformin, metformin, buformin, Sulfonylureas, glibenclamide, chlorpropamide, tolbutamide, glibornuride, tolazamide, carbutamide, glipizide, gliquidone, gliclazide, metahexamide, glisoxepide, glimepiride, acetohexamide, glymidine, Thiazolidinediones, troglitazone, rosiglitazone, pioglitazone, Alpha-glucosidase inhibitors, acarbose, miglitol, voglibose, Meglitinides, repaglinide, nateglinide
Canadian Network for Observational Drug Effect Studies, CNODES, Drug Safety and Effectiveness Network, Canada, Canadian Institutes of Health Research (CIHR)
Type 2 Diabetes Mellitus
05/15
05/15
NCT02958956: Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.

Completed
N/A
236507
NA
Pioglitazone
Takeda
Diabetes Mellitus, Type 2, Cancer
05/15
05/15

Download Options